Vitrum Vision Forte therapy effect in patients with accommodative asthenopia
Yury Sergeyevich Astakhov , Alla Borisovna Lisochkina , Pavel Andreevich Nechiporenko , Aleksandra Ivanovna Titarenko
Ophthalmology Reports ›› 2015, Vol. 8 ›› Issue (4) : 48 -53.
The article presents the results of observational study of Vitrum Vision Forte efficacy in patients with accommodative asthenopia. The changes in asthenopic complaints, Mesotest and computer accomodography data were measured. A decrease in asthenopic complaints’ incidence and severity, a statistically significant increase in mesopic vision and glare sensitivity, a statistically significant reduction in ciliary muscle microfluctuations and accommodative response stability increase were observed.
asthenopia / accommodation / accomodography / Mesotest
| [1] |
Аккомодация: Руководство для врачей. Под ред. Л. А. Катаргиной. М.: Апрель, 2012. |
| [2] |
Сарыгина О. И., Зайцева О. В. Анализ клинической эффективности препарата Витрум Вижн при синдроме «усталого глаза» и возрастной макулярной дегенерации. Вестник офтальмологии. 2005; 121 (5): 43-46. |
| [3] |
Проскурина О. В. Астенопия: клиника, диагностика, лечение. Часть 3. URL: http://sabar.eye-portal.ru. |
| [4] |
Gupta R., Gour D., Meena M. Interventional Cohort Study for evaluation of Computer Vision Syndrome among Computer workers. International Journal of Medical Research and Review. 2014; 2 (1 ): 40-44. |
| [5] |
Husnun Amalia, Gusti G. Suardana, and Widya Artini Accommodative insufficiency as cause of asthenopia in computer-using student. Univ Med. 2010; 29: 78-83. |
| [6] |
Puell M. C., Palomo C., Sanchez-Ramos C., Villena C. Mesopic contrast sensitivity in the presence or absence of glare in a large driver population. Graefe’s Arch Clin Exp Ophthalmol. 2004; 242: 755-761. |
| [7] |
Westmana M., Liinamaa M. J. Relief of asthenopic symptoms with orthoptic exercises in convergence insufficiency is achieved in both adults and children. J Optom. 2012; 5 (2): 62-67. |
| [8] |
Инструкция по эксплуатации Oculus Mesotest II. |
| [9] |
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013; 309 (19): 2005-2015. |
Astakhov Y.S., Lisochkina A.B., Nechiporenko P.A., Titarenko A.I.
/
| 〈 |
|
〉 |